Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S. Aureus Decolonization in Community Adults
NCT04222699Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Sep 2012
- Primary completion
- Nov 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mupirocin and chlorhexidine + cymenol gel in Staphylococcus aureus colonization, sponsored by VA Office of Research & Development. Primary endpoints: Change in the Abundance of Staphylococcus Aureus in the Nose After Decolonization at 8 weeks, Change in the Abundance of Staphylococcus Aureus in the Throat After Decolonization at 8 weeks and 2 more. Started Sep 2012; status: completed.
02
Drugs
mupirocinchlorhexidine + cymenol gel
03
Conditions
Staphylococcus aureus colonization
Beyond the preview
Go deeper on NCT04222699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04222699.